Trump directs more FDA enforcement of pharma adsnews2025-09-09T22:57:25+00:00September 9th, 2025|Endpoints News|
Gilead says it ‘hit the ground running’ on its long-acting HIV shot launchnews2025-08-08T01:57:40+00:00August 8th, 2025|Endpoints News|
Eli Lilly makes all Zepbound doses available in single-dose vials news2025-06-16T19:04:47+00:00June 16th, 2025|Endpoints News|
HHS says it may revisit policy for anti-obesity drugsnews2025-04-07T20:08:01+00:00April 7th, 2025|Endpoints News|
FDA cuts hit drug ad review office, in seeming contradiction with Kennedy’s goalsnews2025-04-01T19:00:29+00:00April 1st, 2025|Endpoints News|
J&J touts new survival data for lung cancer combonews2025-03-26T16:01:33+00:00March 26th, 2025|Endpoints News|
Novo Nordisk slashes Wegovy price for patients without insurance news2025-03-05T16:52:07+00:00March 5th, 2025|Endpoints News|
Misleading promotion lands NJ drugmaker a letter from FDAnews2025-03-04T19:45:44+00:00March 4th, 2025|Endpoints News|
Eli Lilly expands Zepbound single-dose vial options at lower pricenews2025-02-25T11:45:31+00:00February 25th, 2025|Endpoints News|
J&J’s combo beats Tagrisso on survival in first-line lung cancernews2025-01-07T13:00:35+00:00January 7th, 2025|Endpoints News|
